Home DailyMed 0ca29655-4994-4cf8-93db-db8fe6bc7dbf National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 01:08:10 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A061490-001 OXACILLIN SODIUM OXACILLIN SODIUM EQ 250MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 A061490-002 OXACILLIN SODIUM OXACILLIN SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 A061490-003 OXACILLIN SODIUM OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 A061490-004 OXACILLIN SODIUM OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 A061490-006 OXACILLIN SODIUM OXACILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION 1991-05-09
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 215 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A061490-001 OXACILLIN SODIUM EQ 250MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 A061490-002 OXACILLIN SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 A061490-003 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 A061490-004 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 84e616aacf4f…2026-09-14 22:38:34 2026-08 A061490-006 OXACILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION 1991-05-09 84e616aacf4f…2026-08-18 06:07:40 2026-07 A061490-001 OXACILLIN SODIUM EQ 250MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A061490-002 OXACILLIN SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A061490-003 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A061490-004 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A061490-006 OXACILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION 1991-05-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A061490-001 OXACILLIN SODIUM EQ 250MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A061490-002 OXACILLIN SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A061490-003 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A061490-004 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A061490-006 OXACILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION 1991-05-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A061490-001 OXACILLIN SODIUM EQ 250MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A061490-002 OXACILLIN SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A061490-003 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A061490-004 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A061490-006 OXACILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION 1991-05-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A061490-001 OXACILLIN SODIUM EQ 250MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A061490-002 OXACILLIN SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A061490-003 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A061490-004 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A061490-006 OXACILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION 1991-05-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A061490-001 OXACILLIN SODIUM EQ 250MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A061490-002 OXACILLIN SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A061490-003 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A061490-004 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A061490-006 OXACILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION 1991-05-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A061490-001 OXACILLIN SODIUM EQ 250MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A061490-002 OXACILLIN SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A061490-003 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A061490-004 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A061490-006 OXACILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION 1991-05-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A061490-001 OXACILLIN SODIUM EQ 250MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A061490-002 OXACILLIN SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A061490-003 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A061490-004 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION Approved before 1982 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A061490-006 OXACILLIN SODIUM EQ 10GM BASE/VIAL INJECTABLE / INJECTION 1991-05-09 03ed91905a0d…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.